A novel polymer gel for the delivery of local therapies to intracranial tumors: In vivo safety evaluation

David E. Gerber, Gary L. Gallia, Betty M. Tyler, Charles G. Eberhart, Gar Royer, Stuart A. Grossman

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

The treatment of intracranial malignancies is limited by the ability of systemically administered therapies to cross the blood-brain barrier. Royer resorbable matrix, or R-Gel, is a dextran polymer administered in liquid form via needle injection. Within minutes of preparation, the polymer forms a gel and subsequently solidifies, thereby conforming to the dimensions of the injection cavity. R-Gel can accommodate a wide variety of therapeutic agents that may provide new options for local treatment delivery. This preclinical study evaluates the neurotoxicity of R-Gel implanted in the rat brain. Fifteen rats underwent intracranial administration of R-Gel (N = 9) or saline (N = 6) were monitored for systemic and neurotoxicity, and sacrificed at pre-determined time points. Animals that received the R-Gel injection demonstrated no behavioral changes or weight loss. Histopathologic analysis revealed an inflammatory response in both groups on day 3 and day 7 after implantation, which resolved by day 42. These results suggest that intracranial R-Gel is well tolerated. Therapeutic studies of chemotherapy-complexed R-Gel are underway.

Original languageEnglish (US)
Pages (from-to)479-484
Number of pages6
JournalJournal of Biomedical Materials Research - Part A
Volume99 A
Issue number3
DOIs
StatePublished - Dec 1 2011

Fingerprint

Tumors
Polymers
Gels
Rats
Chemotherapy
Dextran
Dextrans
Needles
Brain
Animals
Liquids

Keywords

  • brain tumor
  • glioma
  • interstitial chemotherapy
  • local therapy
  • polymer

ASJC Scopus subject areas

  • Biomedical Engineering
  • Biomaterials
  • Ceramics and Composites
  • Metals and Alloys

Cite this

A novel polymer gel for the delivery of local therapies to intracranial tumors : In vivo safety evaluation. / Gerber, David E.; Gallia, Gary L.; Tyler, Betty M.; Eberhart, Charles G.; Royer, Gar; Grossman, Stuart A.

In: Journal of Biomedical Materials Research - Part A, Vol. 99 A, No. 3, 01.12.2011, p. 479-484.

Research output: Contribution to journalArticle

Gerber, David E. ; Gallia, Gary L. ; Tyler, Betty M. ; Eberhart, Charles G. ; Royer, Gar ; Grossman, Stuart A. / A novel polymer gel for the delivery of local therapies to intracranial tumors : In vivo safety evaluation. In: Journal of Biomedical Materials Research - Part A. 2011 ; Vol. 99 A, No. 3. pp. 479-484.
@article{97dcbd4af01e420399392816a563240c,
title = "A novel polymer gel for the delivery of local therapies to intracranial tumors: In vivo safety evaluation",
abstract = "The treatment of intracranial malignancies is limited by the ability of systemically administered therapies to cross the blood-brain barrier. Royer resorbable matrix, or R-Gel, is a dextran polymer administered in liquid form via needle injection. Within minutes of preparation, the polymer forms a gel and subsequently solidifies, thereby conforming to the dimensions of the injection cavity. R-Gel can accommodate a wide variety of therapeutic agents that may provide new options for local treatment delivery. This preclinical study evaluates the neurotoxicity of R-Gel implanted in the rat brain. Fifteen rats underwent intracranial administration of R-Gel (N = 9) or saline (N = 6) were monitored for systemic and neurotoxicity, and sacrificed at pre-determined time points. Animals that received the R-Gel injection demonstrated no behavioral changes or weight loss. Histopathologic analysis revealed an inflammatory response in both groups on day 3 and day 7 after implantation, which resolved by day 42. These results suggest that intracranial R-Gel is well tolerated. Therapeutic studies of chemotherapy-complexed R-Gel are underway.",
keywords = "brain tumor, glioma, interstitial chemotherapy, local therapy, polymer",
author = "Gerber, {David E.} and Gallia, {Gary L.} and Tyler, {Betty M.} and Eberhart, {Charles G.} and Gar Royer and Grossman, {Stuart A.}",
year = "2011",
month = "12",
day = "1",
doi = "10.1002/jbm.a.33207",
language = "English (US)",
volume = "99 A",
pages = "479--484",
journal = "Journal of Biomedical Materials Research - Part A",
issn = "0021-9304",
publisher = "John Wiley and Sons Inc.",
number = "3",

}

TY - JOUR

T1 - A novel polymer gel for the delivery of local therapies to intracranial tumors

T2 - In vivo safety evaluation

AU - Gerber, David E.

AU - Gallia, Gary L.

AU - Tyler, Betty M.

AU - Eberhart, Charles G.

AU - Royer, Gar

AU - Grossman, Stuart A.

PY - 2011/12/1

Y1 - 2011/12/1

N2 - The treatment of intracranial malignancies is limited by the ability of systemically administered therapies to cross the blood-brain barrier. Royer resorbable matrix, or R-Gel, is a dextran polymer administered in liquid form via needle injection. Within minutes of preparation, the polymer forms a gel and subsequently solidifies, thereby conforming to the dimensions of the injection cavity. R-Gel can accommodate a wide variety of therapeutic agents that may provide new options for local treatment delivery. This preclinical study evaluates the neurotoxicity of R-Gel implanted in the rat brain. Fifteen rats underwent intracranial administration of R-Gel (N = 9) or saline (N = 6) were monitored for systemic and neurotoxicity, and sacrificed at pre-determined time points. Animals that received the R-Gel injection demonstrated no behavioral changes or weight loss. Histopathologic analysis revealed an inflammatory response in both groups on day 3 and day 7 after implantation, which resolved by day 42. These results suggest that intracranial R-Gel is well tolerated. Therapeutic studies of chemotherapy-complexed R-Gel are underway.

AB - The treatment of intracranial malignancies is limited by the ability of systemically administered therapies to cross the blood-brain barrier. Royer resorbable matrix, or R-Gel, is a dextran polymer administered in liquid form via needle injection. Within minutes of preparation, the polymer forms a gel and subsequently solidifies, thereby conforming to the dimensions of the injection cavity. R-Gel can accommodate a wide variety of therapeutic agents that may provide new options for local treatment delivery. This preclinical study evaluates the neurotoxicity of R-Gel implanted in the rat brain. Fifteen rats underwent intracranial administration of R-Gel (N = 9) or saline (N = 6) were monitored for systemic and neurotoxicity, and sacrificed at pre-determined time points. Animals that received the R-Gel injection demonstrated no behavioral changes or weight loss. Histopathologic analysis revealed an inflammatory response in both groups on day 3 and day 7 after implantation, which resolved by day 42. These results suggest that intracranial R-Gel is well tolerated. Therapeutic studies of chemotherapy-complexed R-Gel are underway.

KW - brain tumor

KW - glioma

KW - interstitial chemotherapy

KW - local therapy

KW - polymer

UR - http://www.scopus.com/inward/record.url?scp=80054997144&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80054997144&partnerID=8YFLogxK

U2 - 10.1002/jbm.a.33207

DO - 10.1002/jbm.a.33207

M3 - Article

C2 - 21887743

AN - SCOPUS:80054997144

VL - 99 A

SP - 479

EP - 484

JO - Journal of Biomedical Materials Research - Part A

JF - Journal of Biomedical Materials Research - Part A

SN - 0021-9304

IS - 3

ER -